Oncostem

If there is anyone in the world who can make cancer quiver, it's YOU!
Just because it managed to find a place in your chest doesn't mean you would embrace it.
It's time to tell Cancer to get 'Off Your Chest'.

If there is anyone in the world who can make cancer quiver, it's YOU! Just because it managed to find a place in your chest doesn't mean you would embrace it. It's time to tell Cancer to get 'Off Your Chest'.

What is CanAssist Breast?

CanAssist Breast is our flagship product which uses a proprietary Artificial Intelligence-based statistical model to identify the patient's risk of breast cancer recurrence over five years. It is a prognostic test that analyses the critical biomarkers in the tumour and classifies the patients into "low- risk" or "high-risk" for cancer recurrence. Based on the risk scores, the oncologists can frame an informed and personalized treatment plan wherein the low-risk patients can safely avoid chemotherapy.

Choose the right treatment with CanAssist Breast by weighing the risks and benefits of chemotherapy.

Who qualifies for CanAssist Breast test

Patients with early-stage (Stage I or II), invasive breast cancer

Patients with hormone-receptor-positive (ER+/PR+) and HER2-negative disease

Patients with lymph node negative (NO) or up to three lymph nodes positive (N1) disease

Patients who have not gone through neo-adjuvant chemotherapy

Benefits

Customize cancer treatment based on each patient’s needs

Accuracy of AI-driven biomarker-based prognostic test for Breast Cancer

Industry leading cancer test trusted by oncologists globally

Unique, just like you

Each patient has a unique journey with cancer, making it essential to make informed choices by knowing what works best for them.

Personalized treatment through AI-based Biomarker test

Global quality, validated on Indian Genetic Makeup

Relatable testimonials, not too far from home make a world of a difference. Knowing there are other people like them, fighting it and how, gives them a sense of familiarity & strength.

First test validated on Indian patients which meets global standards

Why CanAssist Breast?

First test to be validated on Indian Patients

Trusted by 300+ Oncologists across the globe

Benefitted 3000+ patients globally, so far

Live life at your own terms

If a patient gets accurate prognosis at the right time, they can avoid chemotherapy and get back to normal life.

Best Innovative Diagnostics Solution" - AEGIS GRAHAM BELL AWARDS

Recognized by Industry Leaders

Aegis Graham Bell Awards 2021

for "Entrepreneur of the Year

Indian Achievers Award 2021

for "Entrepreneur of the Year

Top 25 voices in Precision Medicine Asia 2020

BIS Research and Insight Monk

What Our Beneficiaries Say

OncoStem helped me confirm I could skip Chemotherapy

My surgical oncologist mentioned CanAssist Breast to me, and I’m so glad she did. My medical oncologist and I had decided to skip chemotherapy, so when this test result also came back low-risk, you can imagine how greatly comforting that was to me.

— Breast Cancer Patient, Chennai

*The name and picture have been changed to protect the family's privacy.